Thomas Zander
University of Cologne(DE)Weatherford College(US)Düsseldorf University Hospital(DE)Integrated Oncology (United States)(US)Cancer Research Center(US)Centrum für Integrierte Onkologie(DE)University Hospital Cologne(DE)Heinrich Heine University Düsseldorf(DE)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Spine and Intervertebral Disc Pathology, Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial(2021)2,783 cited
- → Comprehensive genomic profiles of small cell lung cancer(2015)2,338 cited
- → Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing(2012)1,820 cited
- → Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer(2021)1,676 cited
- → Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer(2012)1,405 cited
- → High-throughput oncogene mutation profiling in human cancer(2007)995 cited